BroadOak Partners advises Semrock Inc., a leading provider of optical filters in the life science market, on the sale of the Company to IDEX Corp. (NYSE: IEX).
BroadOak Partners advises Orion Genomics, LLC. on its licensing agreement with Johns Hopkins University over exclusive worldwide rights to the IGF2 gene for Colorectal Cancer Risk testing.
BroadOak Partners advises PharmAthene, Inc. on its acquisition of Avecia Biologics Limiteds vaccines business.
BroadOak Capital Partners advises Martek Biosciences Corp. on the sale of its fluorescent detection products business.
BroadOak Partners granted membership to the NASD (NASD became FINRA on July 27, 2007).